Overview
Personalized medicine is an approach to healthcare that tailors prevention, diagnosis, and treatment to the individual characteristics of each patient, including their genetic, molecular, and clinical profile. Rather than applying uniform protocols, it uses biomarkers and molecular data to predict risk, select therapies most likely to be effective, and minimize adverse effects, aiming for care that is more precise and better matched to the person. The discipline draws on genomics, proteomics, bioinformatics, and increasingly on data-driven analytic tools. The articles gathered here reflect these themes. Molecular profiling is central to work on proteomic and genomic techniques applied to cancer diagnostics and personalized medicine, while the integration of individualized care with nutrition appears in discussion of the progression from personalized medication to customized nutrition. Emerging technologies feature in analysis of artificial intelligence in healthcare and its potential to enhance efficiency and equity. Disease-specific applications include molecular and metabolic characterization of familial combined hyperlipidemia and metabolic syndrome, the prospect of precision approaches in rheumatology, and biomarker monitoring in HIV infection. Together these contributions illustrate the core aims of personalized medicine: using molecular and individual data to stratify patients, guide therapeutic choices, and improve outcomes. The field represents a shift toward care informed by the specific biology of each patient rather than population averages alone.
Research published in this journal
10 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Proteomic and Genomic Techniques in Medical Research: Applications in Cancer, Diagnostics, and Personalized Medicine
Artificial Intelligence in Healthcare: Enhancing Efficiency, Ensuring Equity, and Restoring Empathy
Towards Precision Rheumatology?
Molecular and Metabolic Pathogenesis of Familial Combined Hyperlipidemia and Association with Metabolic Syndrome
Differential of Antioxidant Ability, CD4+T Cells Count and Viral Load in HIV Infected Patients on cART in Yaounde, Cameroon
Transformative Psychopharmacology: the Case of 5-Methoxy-N,N-Dimethyltryptamine
Biotechnology 2.0
Measuring Quality Change in the Market for Anti-Ulcer Drugs
JALR. New Journal, Old questions, Fresh insights
How this research is being cited
The 10 articles above have been cited 3 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.
-
2024 · World Journal of Advanced Research and Reviews
-
V. Chernyshov · 2021 · Ukrainian Therapeutical Journal
-
2021 · Ukrainian Therapeutical Journal
A sample of recent works citing this journal's research on Personalized Medicine, linking to each citing work.